Chen J, Chen X, Ma J
J Ovarian Res. 2025; 18(1):54.
PMID: 40082983
PMC: 11905533.
DOI: 10.1186/s13048-025-01630-5.
Zhang L, Li Y, Li L, Yao F, Cai M, Ye D
Clin Transl Med. 2025; 15(3):e70239.
PMID: 40008496
PMC: 11862898.
DOI: 10.1002/ctm2.70239.
Zhao T, Zhang Z, Chen Z, Xu G, Wang Y, Wang F
Front Oncol. 2025; 15:1534948.
PMID: 39990690
PMC: 11842269.
DOI: 10.3389/fonc.2025.1534948.
Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R
Liver Res. 2025; 8(4):218-236.
PMID: 39958920
PMC: 11771281.
DOI: 10.1016/j.livres.2024.12.001.
Wu H, Chen S, Li X, Li Y, Shi H, Qing Y
MedComm (2020). 2025; 6(1):e70042.
PMID: 39802639
PMC: 11718328.
DOI: 10.1002/mco2.70042.
Multidimensional Proteomic Landscape Reveals Distinct Activated Pathways Between Human Brain Tumors.
Yang S, Zheng Y, Zhou C, Yao J, Yan G, Shen C
Adv Sci (Weinh). 2024; 12(7):e2410142.
PMID: 39716938
PMC: 11831486.
DOI: 10.1002/advs.202410142.
The Quiet Giant: Identification, Effectors, Molecular Mechanism, Physiological and Pathological Function in mRNA 5-methylcytosine Modification.
Wang R, Ding L, Lin Y, Luo W, Xu Z, Li W
Int J Biol Sci. 2024; 20(15):6241-6254.
PMID: 39664561
PMC: 11628344.
DOI: 10.7150/ijbs.101337.
A comprehensive and systematic analysis of Dihydrolipoamide S-acetyltransferase as a novel prognostic biomarker in pan-cancer and glioma.
Zhou H, Yu Z, Xu J, Wang Z, Tao Y, Wang J
Oncol Res. 2024; 32(12):1903-1919.
PMID: 39574473
PMC: 11576973.
DOI: 10.32604/or.2024.048138.
RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer.
Li T, Huang Y, Cui S, Hong Z, Zhang X, Li Z
Sci Rep. 2024; 14(1):26075.
PMID: 39478153
PMC: 11525934.
DOI: 10.1038/s41598-024-77941-2.
A review of current developments in RNA modifications in lung cancer.
Zhang S, Liu Y, Liu K, Hu X, Gu X
Cancer Cell Int. 2024; 24(1):347.
PMID: 39456034
PMC: 11515118.
DOI: 10.1186/s12935-024-03528-6.
NSUN2 knockdown inhibits macrophage infiltration in diabetic nephropathy via reducing N5-methylcytosine methylation of SOCS1.
Wang R, Qu J, Chen M, Han T, Liu Z, Wang H
Int Urol Nephrol. 2024; 57(2):643-653.
PMID: 39382603
DOI: 10.1007/s11255-024-04214-2.
Comprehensive analysis of RNA-5-methylcytosine modification in breast cancer brain metastasis.
Cai P, Li J, An M, Li M, Guo J, Li J
Future Oncol. 2024; 20(37):2993-3008.
PMID: 39345093
PMC: 11572191.
DOI: 10.1080/14796694.2024.2405459.
NSUN2 facilitates tenogenic differentiation of rat tendon-derived stem cells via m5C methylation of KLF2.
Lin W, Lin Z, Wu L, Zheng Y, Xi H
Regen Ther. 2024; 26:792-799.
PMID: 39309399
PMC: 11415532.
DOI: 10.1016/j.reth.2024.08.023.
Exploring the potential mechanism of Xiaojin Pill therapy for benign prostatic hyperplasia through metabolomics and gut microbiota analysis.
Yang Y, Quan Y, Liu Y, Yang J, Chen K, You X
Front Microbiol. 2024; 15:1431954.
PMID: 39234552
PMC: 11371748.
DOI: 10.3389/fmicb.2024.1431954.
Writers, readers, and erasers RNA modifications and drug resistance in cancer.
Chen D, Gu X, Nurzat Y, Xu L, Li X, Wu L
Mol Cancer. 2024; 23(1):178.
PMID: 39215288
PMC: 11363509.
DOI: 10.1186/s12943-024-02089-6.
Targeting treatment resistance: unveiling the potential of RNA methylation regulators and TG-101,209 in pan-cancer neoadjuvant therapy.
Zhou Y, Liu Z, Gong C, Zhang J, Zhao J, Zhang X
J Exp Clin Cancer Res. 2024; 43(1):232.
PMID: 39160604
PMC: 11331809.
DOI: 10.1186/s13046-024-03111-x.
Comparative analyses suggest a link between mRNA splicing, stability, and RNA covalent modifications in flowering plants.
Palos K, Nelson Dittrich A, Lyons E, Gregory B, Nelson A
BMC Plant Biol. 2024; 24(1):768.
PMID: 39134938
PMC: 11318313.
DOI: 10.1186/s12870-024-05486-7.
Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple-Negative Breast Cancer.
Tian W, Zhu L, Luo Y, Tang Y, Tan Q, Zou Y
Adv Sci (Weinh). 2024; 11(36):e2309903.
PMID: 39073262
PMC: 11423137.
DOI: 10.1002/advs.202309903.
Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies.
Yuan W, Zhang R, Lyu H, Xiao S, Guo D, Zhang Q
Cell Death Discov. 2024; 10(1):327.
PMID: 39019857
PMC: 11254935.
DOI: 10.1038/s41420-024-02097-x.
NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression.
Yang Y, Fan H, Liu H, Lou X, Xiao N, Zhang C
Cell Death Dis. 2024; 15(7):506.
PMID: 39013911
PMC: 11252406.
DOI: 10.1038/s41419-024-06899-w.